Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dagmar Simon

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
JAMA Dermatology|November 27, 2024
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 TrialSonja Ständer, Gil Yosipovitch, Franz J Legat, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 19, 2022
An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic SyndromesMichael M Chen, Florence Roufosse, Sa A Wang, et al.
Contact Dermatitis|September 18, 2020
Patch test results with the European baseline series and additions thereof in the ESSCA network, 2015-2018Wolfgang Uter, Andrea Bauer, Anna Belloni Fortina, et al.
Contact Dermatitis|February 23, 2018
European Surveillance System on Contact Allergies (ESSCA): polysensitization, 2009-2014Daan Dittmar, Wolfgang Uter, Andrea Bauer, et al.
Journal of Leukocyte Biology|April 20, 2018
Revisiting the NIH Taskforce on the Research needs of Eosinophil-Associated Diseases (RE-TREAD)Paneez Khoury, Praveen Akuthota, Steven J Ackerman, et al.
Contact Dermatitis|March 17, 2021
European Surveillance System on Contact Allergies (ESSCA): Characteristics of patients patch tested and diagnosed with irritant contact dermatitisLaura Loman, Wolfgang Uter, José C Armario-Hita, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 25, 2025
Consensus on core domains for hand eczema trials: Signs, symptoms, control and quality of lifeHenriette Rönsch, Karl Philipp Drewitz, Amber Reck Atwater, et al.
Allergologie Select|June 22, 2026
Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactationThomas Werfel, Annice Heratizadeh, Matthias Augustin, et al.
Contact Dermatitis|December 31, 2021
Guidelines for diagnosis, prevention, and treatment of hand eczemaJacob P Thyssen, Marie L A Schuttelaar, Jose H Alfonso, et al.
Contact Dermatitis|August 8, 2009
The European baseline series in 10 European Countries, 2005/2006--results of the European Surveillance System on Contact Allergies (ESSCA)Wolfgang Uter, Christiane Rämsch, Werner Aberer, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
JAMA Dermatology|November 27, 2024
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 TrialSonja Ständer, Gil Yosipovitch, Franz J Legat, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 19, 2022
An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic SyndromesMichael M Chen, Florence Roufosse, Sa A Wang, et al.
Contact Dermatitis|September 18, 2020
Patch test results with the European baseline series and additions thereof in the ESSCA network, 2015-2018Wolfgang Uter, Andrea Bauer, Anna Belloni Fortina, et al.
Contact Dermatitis|February 23, 2018
European Surveillance System on Contact Allergies (ESSCA): polysensitization, 2009-2014Daan Dittmar, Wolfgang Uter, Andrea Bauer, et al.
Journal of Leukocyte Biology|April 20, 2018
Revisiting the NIH Taskforce on the Research needs of Eosinophil-Associated Diseases (RE-TREAD)Paneez Khoury, Praveen Akuthota, Steven J Ackerman, et al.
Contact Dermatitis|March 17, 2021
European Surveillance System on Contact Allergies (ESSCA): Characteristics of patients patch tested and diagnosed with irritant contact dermatitisLaura Loman, Wolfgang Uter, José C Armario-Hita, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 25, 2025
Consensus on core domains for hand eczema trials: Signs, symptoms, control and quality of lifeHenriette Rönsch, Karl Philipp Drewitz, Amber Reck Atwater, et al.
Allergologie Select|June 22, 2026
Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactationThomas Werfel, Annice Heratizadeh, Matthias Augustin, et al.
Contact Dermatitis|December 31, 2021
Guidelines for diagnosis, prevention, and treatment of hand eczemaJacob P Thyssen, Marie L A Schuttelaar, Jose H Alfonso, et al.
Contact Dermatitis|August 8, 2009
The European baseline series in 10 European Countries, 2005/2006--results of the European Surveillance System on Contact Allergies (ESSCA)Wolfgang Uter, Christiane Rämsch, Werner Aberer, et al.
Pageof 13